NDC 83301-0024-01 - Bupropion Hydrochloride (XL)
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83301-0024
- Requested NDC
- 83301-0024-01
- Package NDCs from labels
- 83301-0024-1, 83301-0024-2, 83301-0024-3, 83301-0024-4, 83301-0024-01
- Manufacturer
- Mullan Pharmaceutical Inc. | Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd.
- Effective date
- 2026-01-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Bupropion Hydrochloride (XL) | Mullan Pharmaceutical Inc. | Hangzhou Minsheng Binjiang Pharmaceutical Co., Ltd. | 2026-01-29 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83301-0024-1 | Bupropion Hydrochloride (XL) | 30 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 30 | 5 | |
| 83301-0024-2 | Bupropion Hydrochloride (XL) | 90 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 90 | 5 | |
| 83301-0024-3 | Bupropion Hydrochloride (XL) | 500 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 500 | 5 | |
| 83301-0024-4 | Bupropion Hydrochloride (XL) | 1000 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 1000 | 5 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 83301-0024 | BUPROPION HYDROCHLORIDE (XL) (BUPROPION HYDROCHLORIDE) TABLET, EXTENDED RELEASE [MULLAN PHAMACEUTICAL INC.] | 2 | Current NDC, 4 package rows | 20241017_75b1e027-4c5d-46e5-98ee-033e67bd411c.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 83301-0024-1 | EA - Each | 83301-0024 | b557931e-0667-4073-b6e1-03bb26e5f257 | 1 | 2025-08-11 |
| 83301-0024-2 | EA - Each | 83301-0024 | 0a488f1f-a008-4823-92e2-8cf1beb41d5b | 1 | 2025-07-08 |
| 83301-0024-3 | EA - Each | 83301-0024 | b4756bd1-7feb-487f-a470-8fcf84089e77 | 1 | 2025-07-08 |
| 83301-0024-4 | EA - Each | 83301-0024 | 0804598b-02f1-414f-a853-b0052a3af713 | 1 | 2025-07-08 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ReHydration | ADENOSINUM CYCLOPHOSPHORICUM, COFFEA CRUDA, GLANDULA SUPRARENALIS SUIS, HYPOTHALAMUS (BOVINE), KALI PHOSPHORICUM, NATRUM MURIATICUM, SARSAPARILLA, SILICEA, TARAXACUM OFFICINALE, THYROIDINUM (BOVINE) | Energetix Corp | 9883c502-9782-451e-9eec-c54d7b054f31 | 2017-01-31 | Warnings | ETJ7Z6XBU4 |
| Tox-Chord | ALFALFA, ALUMINA, BENZOICUM ACIDUM, CARBONEUM, CETRARIA ISLANDICA, FOLLICULINUM, FUCUS VESICULOSUS, FUMARICUM ACIDUM, HEPAR SUIS, KALI CARBONICUM, KREOSOTUM, NATRUM MURIATICUM, PARAFFINUM, PETROLEUM, PHOSPHORICUM ACIDUM, PHOSPHORUS, PIX LIQUIDA, PLANTAGO MAJOR, PLUMBUM METALLICUM, PULSATILLA (VULGARIS), RADIUM BROMATUM, RESORCINUM, SALOL, SILICEA, SYMPHYTUM OFFICINALE, TABACUM, TEREBINTHINA, THYROIDINUM (BOVINE), TRITICUM REPENS, ZINCUM OXYDATUM | Energetix Corp | 6b0d1628-b20d-426e-9c84-5cceadca3f45 | 2016-11-11 | Warnings | ETJ7Z6XBU4 |
| Thyrotox | CHONDRUS CRISPUS, FUCUS VESICULOSUS, THYROIDINUM, BELLADONNA, CALCAREA CARBONICA, CONIUM MACULATUM, IODIUM, KALI CARBONICUM, PHOSPHORUS, PULSATILLA (VULGARIS), SILICEA | BioActive Nutritional, Inc. | e229a260-13f3-4136-b325-9a8954f8a327 | 2016-08-10 | Warnings | ETJ7Z6XBU4 |
| Teething | ARNICA MONTANA, TRIFOLIUM PRATENSE, CALCAREA CARBONICA, CALCAREA FLUORICA, CALCAREA PHOSPHORICA, CHAMOMILLA, KREOSOTUM, SILICEA | BioActive Nutritional, Inc. | f39c9feb-f567-43a2-a026-2a581aeeed9d | 2016-07-27 | Warnings | ETJ7Z6XBU4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.